MCM
TECH icon

MAI Capital Management’s Bio-Techne TECH Stock Holding History

MAI Capital Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,357
Closed -$70.9K – 4453
2026
Q1 		$70.9K Buy
1,357
+419
+45% +$25.1K ﹤0.01% 2022
2025
Q4 		$55.2K Buy
938
+291
+45% +$17.7K ﹤0.01% 1957
2025
Q3 		$36K Sell
647
-728
-53% -$39K ﹤0.01% 2113
2025
Q2 		$70.7K Buy
1,375
+869
+172% +$43.7K ﹤0.01% 1660
2025
Q1 		$29.7K Buy
506
+91
+22% +$6.17K ﹤0.01% 2007
2024
Q4 		$29.9K Buy
+415
New +$30.5K ﹤0.01% 2035

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

MAI Capital Management's TECH Position: Q2 2026 in Review

MAI Capital Management sold out of Bio-Techne (TECH) in Q2 2026, closing a stake of 1,357 shares — an estimated $70.9K sold.

MAI Capital Management first reported a position in TECH in Q4 2024 and held it in 6 quarters. The position peaked at $70.9K in Q1 2026. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • MAI Capital Management reported no remaining Bio-Techne position as of Q2 2026 after selling out during the quarter.
  • MAI Capital Management sold 1,357 Bio-Techne shares in Q2 2026, an estimated $70.9K.
  • MAI Capital Management first reported a position in Bio-Techne in Q4 2024 and held it in 6 quarters.
  • MAI Capital Management's Bio-Techne position peaked at $70.9K in Q1 2026.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.